Clinical trial
Fluctuation and Realbility of Cardiac Index and SVR/SVRI During Weaning From ECC Regarding Values Obtained From Femoral and Radial Artery Acumen IQ Sensor
NCT06112561 is registered in ClinicalTrials.gov with George Papanicolaou Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluctuation and Realbility of Cardiac Index and SVR/SVRI During Weaning From ECC Regarding Values Obtained From Femoral and Radial Artery Acumen IQ Sensor
- Lead sponsor
- George Papanicolaou Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2024
- Completion date
- May 31, 2024
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic valve disease, coronary artery disease, mitral valve disease